Long-term follow-up of portacaval shunt in glycogen storage disease type 1b

European Journal of Pediatrics

Volumn 159, Issue 4, 2000, Pages 268-272

  Corbeel, Luciem ^a   Van Lierde, Stefaan ^b   Jaeken, Jaak ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Regionaal Ziekenhuis Heilig Hart Tienen   (Belgium)

Author keywords

Ferrit MRI of liver adenoma; Glycogen storage disease type 1b; Portacaval shunt; Quality of life

Indexed keywords

ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STARCH;

ADULT; ARTICLE; CASE REPORT; DIET THERAPY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCOGEN STORAGE DISEASE TYPE 1; GROWTH ACCELERATION; HUMAN; INSULIN BLOOD LEVEL; LIVER ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL HEPATECTOMY; PORTOCAVAL SHUNT; PRIORITY JOURNAL; PUBERTY; QUALITY OF LIFE;

EID: 0034069540     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050068     Document Type: Article

References (19)

1. 1. Beaudet AL, Anderson DC, Michels UV, Arion WJ, Lange AJ (1980) Neutropenia and impaired neutrophil migration in type 1b glycogen storage disease. J Pediatr 97: 906-910
2. 2. Bianchi L (1993) Glycogen storage disease I and hepatocellular tumors. Eur J Pediatr 152 [Suppl 1]: S63-70
3. 3. Borowitz SM, Greene HL, Gay JC, Neblett WW (1987) Comparison of dietary therapy and portacaval shunt in the management of a patient with type 1b glycogen storage disease. J Pediatr Gastroenterol Nutr 6: 635-639
4. 4. Burr IM, O'Neill JA, Karzon DT, Howard LJ, Greene HL (1974) Comparison of the effects of the total parenteral nutrition, continuous intragastric feeding and portacaval shunt on a patient with type 1 glycogen storage disease. J Pediatr 85: 792-795
5. 5. Chen YT, Burchell A (1995) Glycogen Storage Disease. In: Scriver CR, Beaudet AL, Sly WL, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn, vol 1. McGraw-Hill, New York, pp 935-967
6. 6. Corbeel L, Hue L, Lederer B, De Barsy T, Van Den Berghe G, Jaeken J, Bracke P, Eeckels R (1981) Clinical and biochemical findings before and after portacaval shunt in a girl with type 1b glycogen storage disease. Pediatr Res 15: 58-61
7. 7. Corbeel L, Boogaerts M, Van Den Berghe G, Everaerts MC, Marchal G, Eeckels R (1983) Haematological findings in type 1b glycogen storage disease before and after portacaval shunt. Eur J Pediatr 140: 273-275
8. 8. Greene LM, Slonim AE, O'Neill JA, Burr IM (1976) Continuous nocturnal intragastric feeding for management of type 1 glycogen storage disease. N Engl J Med 294: 423-425
9. 9. Kamoun PP (1980) Is type 1b glycogenosis related to an anomeric preference for glucose-6-phosphate uptake by hepatic microsomes? Med Hypotheses 6: 1135-1139
10. 10. Lachaux, A, Boillot O, Stamm D, Canterino I, Dumontet C, Regnier F, Floret D, Hermier M (1993) Treatment with lenogastrim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type 1b. J Pediatr 123: 1005-1008
11. 11. Narisawa K, Igarashi Y, Otomo H, Tada K (1978) A new variant of glycogen storage disease type 1 probably due to a defect in the glucose-6-phosphate transport system. Biochem Biophys Res Commun 83: 1360-1364
12. 12. Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V (1992) Treatment of chronic inflammatory bowel disease in glycogen storage disease type 1b. N Engl J Med 326: 1666-1669
13. 13. Sann L, Mathieu M, Bourgeois J, Bienvenu J, Bethenod M (1980) In vivo evidence for defective activity of glucose-6-phosphatase in type 1b glycogenosis. J Pediatr 96: 691-694
14. 14. Schroten H, Roesler J, Breidenbach Th, Wendel U, Elsner J, Scheitzer S, Zeldler C, Burdach S, Lohmann-Mathes ML, Wahn V, Welte K (1991) Granulocyte and granulocyte macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type 1b. J Pediatr 119: 748-754
15. 15. Smit GPA (1993) The long-term outcome of patients with glycogen storage disease type 1a. Eur J Pediatr 152 [Suppl 1]: S52-55
16. 16. Starzl TE, Putnam CW, Porter KA, Halgrimson CG, Corman J, Brown BI, Gotlin RW, Rodgerson DO, Greene HL (1973) Portal diversion for treatment of glycogen storage disease in humans. Ann Surg 178: 525-538
17. 17. Van Hoof F, Hue L, de Barsy T, Devos P, Hers HG, Jacquemin P (1972) Glycogen storage diseases. Biochimie 54: 745-751
18. 18. Vogl TJ, Hammerstingl R, Schwarz W, Mack MG, Müller PK, Pegios W, Keck H, Eibl-Eibesfeldt A, Hoelzl J, Woessmer B, Bergman C, Felix R (1996) Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198: 881-887
19. 19. Workshop on portacaval shunt in the management of homozygous familial hypercholesterolemia (1974) National Heart and Lung Institute. Division of Heart and Vascular Diseases, Bethesda, Maryland